ClinicalTrials.Veeva

Menu

High Velocity Resistance Training Versus Otago Exercise Training on Falling Risk in Elderly (HVRT/OTAGO)

B

Beni-Suef University

Status

Enrolling

Conditions

Falling Risk

Treatments

Device: High velocity resistance training + Otago Exercise Program

Study type

Interventional

Funder types

Other

Identifiers

NCT07204808
Falling risk

Details and patient eligibility

About

The study aim is to find out the difference between applying the otago exercise training versus high velocity resisted training on risk of fall in elderly. There will be no significant difference between the effect of otago exercise program versus high velocity resisted training on risk of fall in elderly . 40 Old aged persons of both sex their age >65 years and have risk of falling will be recruited in this study.

Full description

Type of study : Randomized trail This prospective interventional study that will be conducted on 40 case of both sex their age above 65

They randomly assigned into 2 equal groups:

Study group (A) 20 patients will receive otago exercise program and will do their normal activity of daily living. Study group (B) 20 patients will receive high velocity resisted training and will do their normal activity of daily living

Enrollment

40 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >65 years old.
  • Both sex.
  • Have limited their activity level due to concern about falling (with or without falling) score by short -FES > 7 and by
  • fall risk check list ≥ 4.
  • Participants will be independently ambulating

Exclusion criteria

  • Any uncontrolled non musculoskeletal conditions that would make testing difficult and uncomfortable such as chronic obstructive airways disease and/or congestive heart failure.
  • A pre-existing neurological condition that affects lower-limb strength, balance and or ambulation (e.g., polio, stroke).
  • Any uncontrolled musculoskeletal or orthopedic conditions that may affect ambulation (e.g. rheumatoid arthritis).
  • Severe cerebrovascular or peripheral venous insufficiency.
  • History of surgery within the past 6 weeks.
  • Sensory impairments (vision, hearing, etc.) that affect communication
  • Previous diagnosis of dementia.
  • Hypotension (systolic blood pressure <90 mmHg, diastolic blood pressure <60 mmHg

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Otago group
Active Comparator group
Description:
Participants who will be randomized to the otago exercise program will receive an exercise program that include 17 exercises 5 for strengthen , 12 balance exercise and will starting and ending with a 2-to 3-min warm-up/cool-down period OEP consists of strengthening and balance exercises. Strengthening of ankle plantar and dorsiflexors, knee extensors and flexors, and hip abductors will be focused in traises. The progression will be performed by increasing the duration and then weights. Stair walking, sit-to-stand, heel-to-toe walking backward, toe walking, heel walking, one-leg stands, tandem walking, tandem stance, sideways walking, turning around, walking backward, walking, and knee bends were used for balance exercises. Three levels will be used for balance exercises: Level 1 will be 2 hands holding on, Level 2 will be one hand holding on, and Level 3 will be no hands or support. The individuals will repeat exercise 10 times session twice a week over 8 weeks
Treatment:
Device: High velocity resistance training + Otago Exercise Program
High velocity resistance training group
Active Comparator group
Description:
Participants who will be randomized to the HVRT will receive an exercise program targeting the lower limbs, to be performed twice a week for 8 weeks. Participants will be instructed to perform the exercises in a rapid and explosive manner such that all repetitions for each shortening phase (concentric activation of the muscle) will be performed as quickly as possible while the lengthening phase of the muscle (eccentric phase) will be controlled over 2-3 s
Treatment:
Device: High velocity resistance training + Otago Exercise Program

Trial contacts and locations

1

Loading...

Central trial contact

Shaimaa Abu bakr bakr, Master degree; Marwa Mohammed Eleawa, Lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems